Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 4

Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review

Authors Rojas J, Patrucco L, Cristiano E

Received 26 December 2013

Accepted for publication 13 March 2014

Published 20 June 2014 Volume 2014:4 Pages 103—109

DOI https://doi.org/10.2147/DNND.S46557

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4


Juan I Rojas, Liliana Patrucco, Edgardo Cristiano

Multiple Sclerosis Center of Buenos Aires, Neurology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

Abstract: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76 cases per 100,000 inhabitants per year. Considering the epidemiology of MS in Argentina, the total number of patients affected is estimated at 5,000–8,000 patients, with nearly 55%–65% of patients having a relapsing-remitting MS subtype of the disease. The aim of this review is to provide an overview of current and emerging treatments available in Argentina for patients with MS.

Keywords: multiple sclerosis, Argentina, treatments, disease-modifying drugs

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]